Apply to trial NCT07622108

A few quick questions so the study team can decide if you might be a fit.

RecruitingPhase 3Drug trial

Treatment of Active Thyroid Eye Disease With MHB018A in a Randomized, Placebo-Controlled Study

The primary objective of this study is to evaluate the efficacy of MHB018A injection compared with placebo in participants with active moderate-to-severe TED.

How this works

Answer a few questions
About 5 to 10 minutes. Skip-friendly where possible.
We connect you with the study team
When a site picks up your application, we introduce you to their team directly — with you on the thread.
The team reaches out to schedule screening
Usually within a few business days, via the contact you give.

EmailWe save your progress under this email and copy you when we connect you with the study team.

I agree that Hipa.ai may share my application — my name, contact details, and my answers, including health information — with the official study team for this trial so they can review my responses and contact me.

By continuing, you agree to our terms of service.

Treatment of Active Thyroid Eye Disease With MHB018A in a Randomized, Placebo-Controlled Study

How this works

Answer a few questions

We connect you with the study team

The team reaches out to schedule screening